Single and Twice-daily Dosing of Ramipril on Renal Function in Chronic Kidney Disease Patients With Reduced Ejection Fraction Heart Failure

NCT07259512 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Disease
Heart Failure With Reduced Ejection Fraction (HFrEF)

Interventions

DRUG: Ramipril

Sponsor

Evi Liliek Wulandari